GTC
NBRV

Ghost Tree Capital’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Ghost Tree Capital’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-800
Closed -$1.01M – 66
2018
Q1 		$1.01M Hold
800
– – 0.2% 50
2017
Q4 		$1.2M Buy
800
+320
+67% +$506K 0.28% 47
2017
Q3 		$983K Buy
+480
New +$1.13M 0.21% 60

Other funds holding NBRV

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

Ghost Tree Capital's NBRV Position: Q2 2018 in Review

Ghost Tree Capital sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q2 2018, closing a stake of 800 shares — an estimated $1.01M sold.

Ghost Tree Capital first reported a position in NBRV in Q3 2017 and held it in 3 quarters. The position peaked at $1.2M in Q4 2017. 42 funds tracked by Wall St. Rank hold NBRV as of Q2 2018.

  • Ghost Tree Capital reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q2 2018 after selling out during the quarter.
  • Ghost Tree Capital sold 800 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q2 2018, an estimated $1.01M.
  • Ghost Tree Capital first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2017 and held it in 3 quarters.
  • Ghost Tree Capital's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $1.2M in Q4 2017.
  • 42 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q2 2018.

Based on Ghost Tree Capital's 13F filing for Q2 2018, filed 14 Aug 2018.